Búsqueda | Biblioteca Virtual en Salud

1.

Buying In.

Winn, Rodger J.

J Natl Compr Canc Netw ; 13(11): 1301-2, 2015 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-26553761

2.

Phase II study of MGI-114 administered intravenously for 5 days every 28 days to patients with metastatic colorectal cancer.

Nasta, Sunita Dwivedy; Hoff, Paulo M; George, Christopher S; Neubauer, Marcus; Cohen, Steven C; Abbruzzese, James; Winn, Rodger; Pazdur, Richard M.

Am J Clin Oncol ; 26(2): 132-4, 2003 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-12714882

3.

Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.

Ozols, Robert F; Herbst, Roy S; Colson, Yolonda L; Gralow, Julie; Bonner, James; Curran, Walter J; Eisenberg, Burton L; Ganz, Patricia A; Kramer, Barnett S; Kris, Mark G; Markman, Maurie; Mayer, Robert J; Raghavan, Derek; Reaman, Gregory H; Sawaya, Raymond; Schilsky, Richard L; Schuchter, Lynn M; Sweetenham, John W; Vahdat, Linda T; Winn, Rodger J.

J Clin Oncol ; 25(1): 146-62, 2007 Jan 01.

Artículo en Inglés | MEDLINE | ID: mdl-17158528

4.

Medical and nursing education and training opportunities to improve survivorship care.

Ferrell, Betty R; Winn, Rodger.

J Clin Oncol ; 24(32): 5142-8, 2006 Nov 10.

Artículo en Inglés | MEDLINE | ID: mdl-17093277

5.

Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.

Herbst, Roy S; Bajorin, Dean F; Bleiberg, Harry; Blum, Diane; Hao, Desirée; Johnson, Bruce E; Ozols, Robert F; Demetri, George D; Ganz, Patricia A; Kris, Mark G; Levin, Bernard; Markman, Maurie; Raghavan, Derek; Reaman, Gregory H; Sawaya, Raymond; Schuchter, Lynn M; Sweetenham, John W; Vahdat, Linda T; Vokes, Everett E; Winn, Rodger J; Mayer, Robert J.

J Clin Oncol ; 24(1): 190-205, 2006 Jan 01.

Artículo en Inglés | MEDLINE | ID: mdl-16326753

6.

Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.

Khuri, Fadlo R; Lee, J Jack; Lippman, Scott M; Kim, Edward S; Cooper, Jay S; Benner, Steven E; Winn, Rodger; Pajak, Thomas F; Williams, Brendell; Shenouda, George; Hodson, Ian; Fu, Karen; Shin, Dong M; Vokes, Everett E; Feng, Lei; Goepfert, Helmuth; Hong, Waun Ki.

J Natl Cancer Inst ; 98(7): 441-50, 2006 Apr 05.

Artículo en Inglés | MEDLINE | ID: mdl-16595780

7.

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.

Smith, Thomas J; Khatcheressian, James; Lyman, Gary H; Ozer, Howard; Armitage, James O; Balducci, Lodovico; Bennett, Charles L; Cantor, Scott B; Crawford, Jeffrey; Cross, Scott J; Demetri, George; Desch, Christopher E; Pizzo, Philip A; Schiffer, Charles A; Schwartzberg, Lee; Somerfield, Mark R; Somlo, George; Wade, James C; Wade, James L; Winn, Rodger J; Wozniak, Antoinette J; Wolff, Antonio C.

J Clin Oncol ; 24(19): 3187-205, 2006 Jul 01.

Artículo en Inglés | MEDLINE | ID: mdl-16682719

8.

Ongoing care of patients after primary treatment for their cancer.

Kattlove, Herman; Winn, Rodger J.

CA Cancer J Clin ; 53(3): 172-96, 2003.

Artículo en Inglés | MEDLINE | ID: mdl-12809410

9.

The NCCN clinical practice guidelines in oncology: a primer for users.

Winn, Rodger J; McClure, Joan.

J Natl Compr Canc Netw ; 1(1): 5-13, 2003 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-19764146

10.

What are the most important symptom targets when treating advanced cancer? A survey of providers in the National Comprehensive Cancer Network (NCCN).

Cella, David; Paul, Diane; Yount, Susan; Winn, Rodger; Chang, Chih-Hung; Banik, Donald; Weeks, Jane.

Cancer Invest ; 21(4): 526-35, 2003.

Artículo en Inglés | MEDLINE | ID: mdl-14533442

11.

Myeloid Growth Factor Guidelines: moving toward a societal perspective.

Winn, Rodger J.

J Natl Compr Canc Netw ; 5(2): 117, 2007 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-17366693

12.

Where are we headed: the value of updating guidelines.

Winn, Rodger J.

J Natl Compr Canc Netw ; 4(1): 1, 2006 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-16403399

13.

Localized renal cell cancer: a testing ground for new approaches and technology.

Winn, Rodger J.

J Natl Compr Canc Netw ; 3(1): 1-2, 2005 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-19813318

14.

The silos of medical literature.

Winn, Rodger J.

J Natl Compr Canc Netw ; 3(2): 117, 2005 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-19817022

15.

To dream the possible dream.

Winn, Rodger J.

J Natl Compr Canc Netw ; 3(2): 118-21, 2005 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-19817023

16.

If only it were simple.

Winn, Rodger J.

J Natl Compr Canc Netw ; 3(6): 731, 2005 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-16316610

17.

Technology and the operating room.

Winn, Rodger J.

J Natl Compr Canc Netw ; 3(5): 597, 2005 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-16194452

18.

Competing outcomes.

Winn, Rodger J.

J Natl Compr Canc Netw ; 3(4): 467, 2005 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-16038638

19.

Targeted therapy in the macro mode.

Winn, Rodger J.

J Natl Compr Canc Netw ; 3(3): 235-6, 2005 May.

Artículo en Inglés | MEDLINE | ID: mdl-16001999

20.

Diverging opinions on interferon therapy for melanoma.

Winn, Rodger J.

J Natl Compr Canc Netw ; 2(1): 1, 2004 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-19777689

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar:

Buying In.

Phase II study of MGI-114 administered intravenously for 5 days every 28 days to patients with metastatic colorectal cancer.

Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.

Medical and nursing education and training opportunities to improve survivorship care.

Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.

Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.

Ongoing care of patients after primary treatment for their cancer.

The NCCN clinical practice guidelines in oncology: a primer for users.

What are the most important symptom targets when treating advanced cancer? A survey of providers in the National Comprehensive Cancer Network (NCCN).

Myeloid Growth Factor Guidelines: moving toward a societal perspective.

Where are we headed: the value of updating guidelines.

Localized renal cell cancer: a testing ground for new approaches and technology.

The silos of medical literature.

To dream the possible dream.

If only it were simple.

Technology and the operating room.

Competing outcomes.

Targeted therapy in the macro mode.

Diverging opinions on interferon therapy for melanoma.